ProCE Banner Activity

CE / CME

Increased Risk of HIV Acquisition Among Transgender Individuals

Text Module

In this module, an HIV specialist reviews the latest data on HIV prevalence in the transgender population and discusses measures healthcare professionals can take to reduce HIV transmission and improve retention in care among transgender individuals.

Pharmacists: 0.75 contact hour (0.075 CEUs)

Nurses: 0.75 Nursing contact hour

Physicians: Maximum of 0.75 AMA PRA Category 1 Credit

Released: September 27, 2022

Expiration: September 26, 2023

No longer available for credit.

Share

Faculty

Antonio E. Urbina

Antonio E. Urbina, MD

Associate Medical Director
Department of Medicine
St Luke-Roosevelt Hospitals
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Merck Sharp & Dohme Corp.

Target Audience

This educational program is intended for all healthcare professionals across multiple disciplines and specialties who care for transgender individuals, including medical oncologists, gynecologists, HIV specialists, primary care physicians, pharmacists, nurses, nurse practitioners, and physician assistants.

Program Learning Goal

The goal of this education is to advance knowledge, competence, and performance of healthcare professionals to ensure they are providing inclusive care for all patients, including cancer screening and preventive care for transgender individuals.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Implement strategies to build a compassionate and inclusive healthcare environment to foster a comfortable and trusting relationship between healthcare professionals and transgender individuals
  • Plan effective screening and cancer prevention plans based on an anatomical checklist consistent with the patient’s current anatomical structure

  • Discuss with the multidisciplinary team the importance of recognizing that not all persons identify as male or female but may retain organs that put them at risk for developing cancer
  • Evaluate the potentially disproportionately increased risk of transgender individuals for contracting HIV and the increased risk of developing several types of cancers

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Antonio E. Urbina, MD

Associate Medical Director
Department of Medicine
St Luke-Roosevelt Hospitals
New York, New York

Antonio Urbina, MD: consultant/advisor/speaker: Gilead Sciences, Janssen, Merck, ViiV

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Kristi Kay Orbaugh, MSN, NP, APCNP as noted below:

Kristi Orbaugh, MSN, NP, AOCNP: speaker bureau: AstraZeneca, Bristol-Myers Squibb, DSI, Gilead Sciences, Lilly, Morphosys, Pfizer, Regeneron, Sanofi.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from September 27, 2022, through September 26, 2023:

1. Login or Sign Up for an account by clicking at the top of this page.

2. Read the target audience, learning objectives, and faculty disclosures.

3. Study the educational activity online or printed out.

4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-228-H01-P

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 65% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.